{
    "rcn": "212692",
    "acronym": "TAXINOMISIS",
    "topics": "SC1-PM-02-2017",
    "title": "A multidisciplinary approach for the stratification of patients with carotid artery disease",
    "startDate": "01/01/2018",
    "endDate": "31/12/2022",
    "objective": "Carotid artery disease, the primary trigger of ischaemic cerebrovascular events including stroke, causes major morbidity, mortality and healthcare costs worldwide. Still, treatment is based on criteria established in the 90s that do not take into account the molecular evolution we have witnessed since, nor the introduction of new medication, leading to remarkably high unnecessary surgical treatment while missing most patients at risk. \nTAXINOMISIS will provide novel disease mechanism-based stratification for carotid artery disease patients to address the needs for stratified and personalised therapeutic interventions in the current era. This will be achieved through (1) the dissection of mechanisms mediating carotid artery disease, and identification of susceptibility and protection factors of plaque erosion and/or rupture using longitudinal cohorts and multi-omics, (2) the definition of distinct disease phenotypes and endotypes, and generation of molecular fingerprints of high versus low-risk states through systems medicine, (3) the development of a multilevel risk prediction model of the symptomatic plaque incorporating new biomarkers and advanced imaging, implemented in a software, to assist patient stratification and clinical decision making, (4) the development of novel pharmacogenomics solutions based on lab-on-a-chip technology to support personalized treatment, (5) the evaluation of the new risk prediction model and lab-on-a-chip device in a prospective observational clinical study, and (6) the assessment of regulatory, cost-effectiveness and ethical issues towards the implementation and commercialization of the programme√≠s outcomes.\nTAXINOMISIS has therefore the potential to rationally change the current state-of-the-art in the stratification of patients with carotid artery disease by reducing unnecessary operations, refining medical treatment and opening up new avenues for therapeutic intervention, while strengthening the European biotechnology sector.",
    "totalCost": "5999402,5",
    "ecMaxContribution": "5999402,5",
    "coordinator": "PANEPISTIMIO IOANNINON",
    "coordinatorCountry": "EL",
    "participants": "ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO;Fair Dynamics Consulting s.r.l.;STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG;ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON;PIRKANMAA HOSPITAL DISTRICT;INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM;FACULTY OF MEDICINE, UNIVERSITY OF BELGRADE;EUROPEAN SOCIETY FOR CARDIOVASCULAR AND ENDOVASCULAR SURGERY;IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON;ZORA BIOSCIENCES OY;FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA;UNIVERSITAIR MEDISCH CENTRUM UTRECHT;IRCCS OSPEDALE POLICLINICO SAN MARTINO;KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD",
    "participantCountries": "RS;IT;NL;EL;FI;BE;CH;ES;DE;UK",
    "projectParticipants": {
        "999915189": {
            "orgId": "999915189",
            "orgName": "UNIVERSITAIR MEDISCH CENTRUM UTRECHT",
            "ecContrib": 816656
        },
        "999981149": {
            "orgId": "999981149",
            "orgName": "INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM",
            "ecContrib": 799559
        },
        "997234012": {
            "orgId": "997234012",
            "orgName": "ISTRAZIVACKO RAZVOJNI CENTAR ZA BIOINZENJERING BIOIRC DOO",
            "ecContrib": 181250
        },
        "999643007": {
            "orgId": "999643007",
            "orgName": "ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON",
            "ecContrib": 225000
        },
        "998294125": {
            "orgId": "998294125",
            "orgName": "STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG",
            "ecContrib": 183750
        },
        "999555028": {
            "orgId": "999555028",
            "orgName": "ZORA BIOSCIENCES OY",
            "ecContrib": 400000
        },
        "999891424": {
            "orgId": "999891424",
            "orgName": "FACULTY OF MEDICINE, UNIVERSITY OF BELGRADE",
            "ecContrib": 350000
        },
        "911279402": {
            "orgId": "911279402",
            "orgName": "EUROPEAN SOCIETY FOR CARDIOVASCULAR AND ENDOVASCULAR SURGERY",
            "ecContrib": 59375
        },
        "929803880": {
            "orgId": "929803880",
            "orgName": "Fair Dynamics Consulting s.r.l.",
            "ecContrib": 291250
        },
        "999875710": {
            "orgId": "999875710",
            "orgName": "KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN",
            "ecContrib": 302500
        },
        "999622443": {
            "orgId": "999622443",
            "orgName": "IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON",
            "ecContrib": 550312
        },
        "999460065": {
            "orgId": "999460065",
            "orgName": "PIRKANMAA HOSPITAL DISTRICT",
            "ecContrib": 396250
        },
        "999852818": {
            "orgId": "999852818",
            "orgName": "PANEPISTIMIO IOANNINON",
            "ecContrib": 751375
        },
        "999984350": {
            "orgId": "999984350",
            "orgName": "THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD",
            "ecContrib": 304000
        }
    },
    "calculatedTotalContribution": 5611277
}